Summary
Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. It is developing solutions to address various underserved conditions. The company seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the benefits they may have in certain cases involving depression, mental health issues, and neurological disorders. The company focuses on merging traditional therapeutics with psychedelic research for people suffering from indications, such as depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.
History
Silo Pharma was established in 1984 by a group of scientists, chemists, and engineers. With a commitment to innovation and customer service, the company quickly grew to become a leader in the pharmaceutical industry. Over the years, we have invested in research, development, manufacturing, and marketing, and our portfolio of products has grown to include a wide range of products and services for the medical industry.
Mission
Our mission is to provide innovative and patient-centric pharmaceutical solutions that meet the needs of medical professionals worldwide.
Vision
Our vision is to be the leading provider of high-quality and innovative pharmaceuticals that serve to extend and improve the lives of our patients.
Key Team
Mr. Eric Weisblum (Chairman, Pres & CEO)
Mr. Daniel E. Ryweck (Chief Financial Officer)
Dr. James S. Kuo M.B.A., M.D. (VP of R&D)
Recognition and Awards
Silo Pharma has been consistently recognized for its commitment to excellence and innovation. We have been recognized with numerous awards, including the CPhI Pharma Award for Excellence in Drug Innovation, and the Pharma Brand of the Year Award. Additionally, we have been recognized as a top-tier research and development laboratory by several global organizations.
References
